16-31094694-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_ModerateBP6_ModerateBP7BS1BS2

The NM_024006.6(VKORC1):​c.36G>A​(p.Arg12Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0119 in 1,608,310 control chromosomes in the GnomAD database, including 230 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). Synonymous variant affecting the same amino acid position (i.e. R12R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.013 ( 32 hom., cov: 32)
Exomes 𝑓: 0.012 ( 198 hom. )

Consequence

VKORC1
NM_024006.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 1.38

Publications

11 publications found
Variant links:
Genes affected
VKORC1 (HGNC:23663): (vitamin K epoxide reductase complex subunit 1) This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]
VKORC1 Gene-Disease associations (from GenCC):
  • vitamin K-dependent clotting factors, combined deficiency of, type 2
    Inheritance: Unknown, AR Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
  • vitamin K-dependent clotting factors, combined deficiency of, type 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.34).
BP6
Variant 16-31094694-C-T is Benign according to our data. Variant chr16-31094694-C-T is described in ClinVar as Benign. ClinVar VariationId is 318977.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=1.38 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAdExome4 allele frequency = 0.0118 (17223/1455944) while in subpopulation AMR AF = 0.0164 (729/44336). AF 95% confidence interval is 0.0155. There are 198 homozygotes in GnomAdExome4. There are 8352 alleles in the male GnomAdExome4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 32 AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VKORC1NM_024006.6 linkc.36G>A p.Arg12Arg synonymous_variant Exon 1 of 3 ENST00000394975.3 NP_076869.1 Q9BQB6-1A0A0S2Z6I4
VKORC1NM_001311311.2 linkc.36G>A p.Arg12Arg synonymous_variant Exon 1 of 4 NP_001298240.1 Q9BQB6
VKORC1NM_206824.3 linkc.36G>A p.Arg12Arg synonymous_variant Exon 1 of 2 NP_996560.1 Q9BQB6-3A0A0S2Z5X7
LOC124903680XM_047435012.1 linkc.*190G>A downstream_gene_variant XP_047290968.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VKORC1ENST00000394975.3 linkc.36G>A p.Arg12Arg synonymous_variant Exon 1 of 3 1 NM_024006.6 ENSP00000378426.2 Q9BQB6-1
ENSG00000255439ENST00000529564.1 linkc.36G>A p.Arg12Arg synonymous_variant Exon 1 of 5 4 ENSP00000431371.1 E9PLN8

Frequencies

GnomAD3 genomes
AF:
0.0131
AC:
1990
AN:
152248
Hom.:
32
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00229
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0155
Gnomad ASJ
AF:
0.0210
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.0750
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0111
Gnomad OTH
AF:
0.0124
GnomAD2 exomes
AF:
0.0151
AC:
3528
AN:
233556
AF XY:
0.0144
show subpopulations
Gnomad AFR exome
AF:
0.00210
Gnomad AMR exome
AF:
0.0158
Gnomad ASJ exome
AF:
0.0226
Gnomad EAS exome
AF:
0.0000559
Gnomad FIN exome
AF:
0.0735
Gnomad NFE exome
AF:
0.0117
Gnomad OTH exome
AF:
0.0230
GnomAD4 exome
AF:
0.0118
AC:
17223
AN:
1455944
Hom.:
198
Cov.:
32
AF XY:
0.0115
AC XY:
8352
AN XY:
724318
show subpopulations
African (AFR)
AF:
0.00120
AC:
40
AN:
33450
American (AMR)
AF:
0.0164
AC:
729
AN:
44336
Ashkenazi Jewish (ASJ)
AF:
0.0224
AC:
583
AN:
26058
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39604
South Asian (SAS)
AF:
0.00171
AC:
147
AN:
85900
European-Finnish (FIN)
AF:
0.0695
AC:
3457
AN:
49744
Middle Eastern (MID)
AF:
0.00139
AC:
8
AN:
5752
European-Non Finnish (NFE)
AF:
0.0104
AC:
11538
AN:
1110922
Other (OTH)
AF:
0.0120
AC:
721
AN:
60178
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1259
2518
3776
5035
6294
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
436
872
1308
1744
2180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0131
AC:
1991
AN:
152366
Hom.:
32
Cov.:
32
AF XY:
0.0154
AC XY:
1150
AN XY:
74510
show subpopulations
African (AFR)
AF:
0.00228
AC:
95
AN:
41588
American (AMR)
AF:
0.0154
AC:
236
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0210
AC:
73
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.00166
AC:
8
AN:
4832
European-Finnish (FIN)
AF:
0.0750
AC:
797
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0111
AC:
755
AN:
68044
Other (OTH)
AF:
0.0123
AC:
26
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
107
214
322
429
536
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00964
Hom.:
6
Bravo
AF:
0.00914
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Vitamin K-dependent clotting factors, combined deficiency of, type 2 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.34
CADD
Benign
15
DANN
Benign
0.94
PhyloP100
1.4
PromoterAI
0.032
Neutral
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55894764; hg19: chr16-31106015; API